One systematic review, a meta-analysis, and three narrative reviews observed that hyperuricemia may cause insulin resistance, oxidative stress, endothelial dysfunction, and inflammation which form the basis for MetS, and XO inhibitors are effective. Here, XDH is linked to metabolic syndrome.